Viewing Study NCT06600711



Ignite Creation Date: 2024-10-26 @ 3:40 PM
Last Modification Date: 2024-10-26 @ 3:40 PM
Study NCT ID: NCT06600711
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-09-16

Brief Title: Nitazoxanide for Treatment of Cryptosporidium in Children
Sponsor: None
Organization: None

Study Overview

Official Title: Randomized Control Trial of Nitazoxanide for the Treatment of Cryptosporidium Infection in Malnourished Children in Bangladesh
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this clinical trial is to learn if nitazoxanide NTZ can treat Cryptosporidium infection in children age 6-12 months The main questions it aims to answer are

Does NTZ treatment of diarrheal Cryptosporidium infection lower the number of days of diarrhea
Does NTZ treatment of diarrheal and non-diarrheal Cryptosporidium infection lower the number of days that parasites can be found in the stool

Researchers will compare NTZ to a placebo a look-alike substance that contains no drug to see if NTZ works to treat Cryptosporidium

Participants will

Take NTZ or placebo for 3 days
Receive regular visits from field research assistants
Provide blood and urine samples
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None